Glaucoma

FDA approves of iDose TR (travoprost intracameral implant)

The U.S. Food and Drug Administration has approved iDose TR (travoprost intracameral implant) 75 mcg, a prostaglandin analog indicated for the reduction of intraocular pressure (IOP) in patients with ocular hypertension (OHT) or open-angle glaucoma (OAG), according to a press release. The FDA has granted approval for the slow-release iDose...